Committee Report: Glycemic targets for elderly patients with diabetes

نویسنده

  • Masakazu Haneda
چکیده

doi: 10.1111/jdi.12599 With the accelerated aging of society, the number of elderly patients with diabetes continues to rise in Japan. The elderly have specific health problems that vary widely among individuals. In particular, susceptibility to severe hypoglycemia is a hallmark of elderly diabetes. Severe hypoglycemia not only impairs cognitive function but can also increase the risk of cardiovascular events. Against this background, the Japan Diabetes Society (JDS)/Japan Geriatrics Society (JGS) Joint Committee on Improving Care for Elderly Patients with Diabetes was launched in April 2015. As a first step toward developing ‘Clinical Practice Guidelines for the Management of Elderly Patients with Diabetes’, the Joint Committee launched an in-depth debate on glycemic targets for elderly diabetes. Over a series of discussions, the Joint Committee drew on the available reports on glycemic targets for the elderly, which included the Japanese Elderly Diabetes Intervention Trial (JEDIT) study, the American Diabetes Association (ADA)/ American Geriatrics Society (AGS) Consensus report, International Diabetes Federation (IDF)’s Global Guideline, and other relevant reports in the pertinent literature, and developed the ‘Glycemic Targets for Elderly Patients with Diabetes’ described in Figure 1 shown below. The Joint Committee’s consensus is summarized as follows: 1. The glycemic target is to be determined for each elderly patient by taking into account the patient’s background characteristics and health status (e.g., age, cognitive function, physical function [basic and instrumental activities of daily living {ADL}]), comorbidities, risk for severe hypoglycemia, and life expectancy; 2. The lower limit of the glycemic target is to be targeted to ensure safer glycemic control in those likely to be at risk of severe hypoglycemia; and 3. The Joint Committee’s recommendations allow the glycemic targets to be adjusted to exceed or fall below the glycemic targets suggested in the Table to ensure patient-centered care while providing the glycemic targets and their lower limits as a basis for glycemic control in elderly patients with diabetes.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report

The Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, the common risk factors for diabetes and cancer, and cancer risk associated with diabetes treatment. The Joint Committee continued its work to assess the role of glycemi...

متن کامل

Management of Type 2 Diabetes Mellitus in Older Patients: Current and Emerging Treatment Options

Elderly patients with type 2 diabetes mellitus (T2DM) are a rapidly emerging population that presents unique clinical challenges. This diverse patient group can differ widely in terms of physical and mental status, which can increase their risk of complications including hypoglycemia, falls, and depression. These factors can negatively impact their glycemic control, safety, and quality of life....

متن کامل

A Review of the Relationship between Dietary Glycemic Index and Glycemic Load and Type 2 Diabetes

Background: In recent decades, studies on type 2 diabetes (T2D), have adopted a new approach to the field of a more complete collection of variables related to the lifestyles and diet of people. Diet is an important factor in increasing the rate of T2D among individuals. Considering the consumption of a high-carbohydrate diet, little attention has been paid to the type of carbohydrates consumed...

متن کامل

Associated factors of poor glycemic control in Iranian diabetic patients

Introduction: According to the world health organization the prevalence of type 2 diabetes in our country and world will increase sharply by 2030. Because improving glycemic control delays the onset and progression of diabetes complications, recognizing related factors is key step in the effective treatment of these patients. Therefore, this study was performed to determine the predictors of po...

متن کامل

Safety of sodium-glucose co-transporter 2 inhibitors during Ramadan fasting: Evidence, perceptions and guidelines

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new glucose-lowering therapy for T2DM with documented benefits on blood glucose, hypertension, weight reduction and long term cardiovascular benefit. They have an inherent osmotic diuretic effect and lead to some volume loss and possible dehydration. There is some concern about the safety of using SGLT2 inhibitors in Muslim type 2 diabete...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 8  شماره 

صفحات  -

تاریخ انتشار 2017